OP449 inhibits breast cancer growth without adverse metabolic effects
Gadi Shlomai(Icahn School of Medicine at Mount Sinai), Emily J. Gallagher(Icahn School of Medicine at Mount Sinai)
Cited by 17
Related Papers
Insulin resistance contributes to racial disparities in breast cancer prognosis in US women
|Breast Cancer Research|2020|64
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice
|Endocrine Related Cancer|2016|32
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors
|Journal of Cancer Research and Clinical Oncology|2022|23